Skip to main content
Erschienen in: World Journal of Surgery 12/2020

05.09.2020 | Original Scientific Report

Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio

verfasst von: Shunsuke Nakamura, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera

Erschienen in: World Journal of Surgery | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to clarify the utility of lymph node ratio (LNR) for assessing the prognosis of patients with node-positive gastric cancer after curative gastrectomy.

Methods

We retrospectively analyzed data of 973 patients with node-positive gastric cancer who had undergone curative gastrectomy at nine institutions from 2010 to 2014. Survival analysis was performed by comparing LNR low and high groups according to the optimal cutoff value of LNR, which was determined using receiver operating characteristic curve analysis.

Results

LNR high was significantly associated with shorter disease-free survival and was an independent predictor of recurrence in all patients. Moreover, we obtained the similar results from analysis of each N stage. The prevalence of lymph node and peritoneal recurrence appeared to be higher in the LNR high group. Correlation analysis showed that LNR was negatively correlated with the number of retrieved nodes within every N stage; however, disease-free survival did not differ significantly between LNR low and high groups of each N stage with 16–30, 31–40, or >40 retrieved nodes.

Conclusions

LNR is a strong prognostic factor and predictor of recurrence in patients with node-positive gastric cancer who have undergone curative gastrectomy. The combination of LNR and N staging permits more accurate prognostic stratification of patients with gastric cancer and may contribute to developing novel prognostic models.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yamashita H, Deng J, Liang H et al (2017) Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients. Surgery 161:1588–1596CrossRef Yamashita H, Deng J, Liang H et al (2017) Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients. Surgery 161:1588–1596CrossRef
2.
Zurück zum Zitat Ren G, Cai R, Zhang WJ et al (2013) Prediction of risk factors for lymph node metastasis in early gastric cancer. World J Gastroenterol 19:3096–3107CrossRef Ren G, Cai R, Zhang WJ et al (2013) Prediction of risk factors for lymph node metastasis in early gastric cancer. World J Gastroenterol 19:3096–3107CrossRef
3.
Zurück zum Zitat Kanda M, Suh YS, Park DJ et al (2019) Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer 23:203–211CrossRef Kanda M, Suh YS, Park DJ et al (2019) Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer 23:203–211CrossRef
4.
Zurück zum Zitat Hayashi S, Kanda M, Ito S et al (2019) Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 22:853–863CrossRef Hayashi S, Kanda M, Ito S et al (2019) Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 22:853–863CrossRef
5.
Zurück zum Zitat Kanda M, Ito S, Mochizuki Y et al (2019) Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med 8:5194–5201CrossRef Kanda M, Ito S, Mochizuki Y et al (2019) Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med 8:5194–5201CrossRef
6.
Zurück zum Zitat Ito Y, Kanda M, Ito S et al (2020) Prognosis after laparoscopic gastrectomy in patients with pathological stage II or III gastric cancer who were preoperatively diagnosed with clinical stage I: propensity score matching analysis of a multicenter dataset. AnnSurg Oncol 27:268–275 Ito Y, Kanda M, Ito S et al (2020) Prognosis after laparoscopic gastrectomy in patients with pathological stage II or III gastric cancer who were preoperatively diagnosed with clinical stage I: propensity score matching analysis of a multicenter dataset. AnnSurg Oncol 27:268–275
7.
Zurück zum Zitat Kutlu OC, Watchell M, Dissanaike S (2015) Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol. 24:84–88CrossRef Kutlu OC, Watchell M, Dissanaike S (2015) Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol. 24:84–88CrossRef
8.
Zurück zum Zitat Melis M, Masi A, Pinna A et al (2015) Does lymph node ratio affect prognosis in gastroesophageal cancer? Am J Surg 210:443–450CrossRef Melis M, Masi A, Pinna A et al (2015) Does lymph node ratio affect prognosis in gastroesophageal cancer? Am J Surg 210:443–450CrossRef
9.
Zurück zum Zitat Liu H, Deng J, Zhang R et al (2013) The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer. Int J Surg 11:419–424CrossRef Liu H, Deng J, Zhang R et al (2013) The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer. Int J Surg 11:419–424CrossRef
10.
Zurück zum Zitat Marchet A, Mocellin S, Ambrosi A et al (2008) The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 34:159–165CrossRef Marchet A, Mocellin S, Ambrosi A et al (2008) The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 34:159–165CrossRef
11.
Zurück zum Zitat Chen S, Zhao BW, Li YF et al (2012) The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS ONE 7:e49424CrossRef Chen S, Zhao BW, Li YF et al (2012) The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS ONE 7:e49424CrossRef
12.
Zurück zum Zitat Sianesi M, Bezer L, Del Rio P et al (2010) The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg 14:614–619CrossRef Sianesi M, Bezer L, Del Rio P et al (2010) The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg 14:614–619CrossRef
13.
Zurück zum Zitat Hou Y, Wang X, Chen J (2018) Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol 16:198CrossRef Hou Y, Wang X, Chen J (2018) Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol 16:198CrossRef
14.
Zurück zum Zitat Wu XJ, Miao RL, Li ZY et al (2015) Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol 41:927–933CrossRef Wu XJ, Miao RL, Li ZY et al (2015) Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol 41:927–933CrossRef
15.
Zurück zum Zitat Wang J, Dang P, Raut CP et al (2012) Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 255:478–485CrossRef Wang J, Dang P, Raut CP et al (2012) Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 255:478–485CrossRef
16.
Zurück zum Zitat Yang ZL, Zhu MH, Han XJ et al (2019) Modified American joint committee on cancer tumor-node-metastasis staging system based on the node ratio can further improve the capacity of prognosis assessment for gastric cancer patients. Front Oncol 9:329CrossRef Yang ZL, Zhu MH, Han XJ et al (2019) Modified American joint committee on cancer tumor-node-metastasis staging system based on the node ratio can further improve the capacity of prognosis assessment for gastric cancer patients. Front Oncol 9:329CrossRef
17.
Zurück zum Zitat Japanese Gastric Cancer (2017) A Japanese gastric cancer treatment guidelines 2014 (ver.4). Gastric Cancer 20:1–19CrossRef Japanese Gastric Cancer (2017) A Japanese gastric cancer treatment guidelines 2014 (ver.4). Gastric Cancer 20:1–19CrossRef
18.
Zurück zum Zitat Nakanishi K, Kanda M, Ito S et al (2019) Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset. Gastric Cancer 22:1215–1225CrossRef Nakanishi K, Kanda M, Ito S et al (2019) Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset. Gastric Cancer 22:1215–1225CrossRef
19.
Zurück zum Zitat Kanda M, Murotani K, Kobayashi D et al (2015) Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: a propensity score matching analysis. Surgery 158:1573–1580CrossRef Kanda M, Murotani K, Kobayashi D et al (2015) Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: a propensity score matching analysis. Surgery 158:1573–1580CrossRef
20.
Zurück zum Zitat Hwang JE, Kim H, Shim HJ et al (2019) Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer. J Cancer Res Clin Oncol 145:2157–2166CrossRef Hwang JE, Kim H, Shim HJ et al (2019) Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer. J Cancer Res Clin Oncol 145:2157–2166CrossRef
21.
Zurück zum Zitat Fang C, Wang W, Deng JY et al (2018) Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation. Cancer Commun (Lond) 38:67CrossRef Fang C, Wang W, Deng JY et al (2018) Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation. Cancer Commun (Lond) 38:67CrossRef
22.
Zurück zum Zitat Haejin In, Solsky I, Palis B et al (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24:3683–3691CrossRef Haejin In, Solsky I, Palis B et al (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24:3683–3691CrossRef
23.
Zurück zum Zitat Wang W, Xu DZ, Li YF et al (2011) Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a single-institution study of 1343 Chinese patients. Ann Oncol 22(9):2049–2056CrossRef Wang W, Xu DZ, Li YF et al (2011) Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a single-institution study of 1343 Chinese patients. Ann Oncol 22(9):2049–2056CrossRef
24.
Zurück zum Zitat Deng J, Zhang R, Wu L et al (2015) Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer. Ann Surg Oncol 22:1258–1266CrossRef Deng J, Zhang R, Wu L et al (2015) Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer. Ann Surg Oncol 22:1258–1266CrossRef
25.
Zurück zum Zitat Bouliaris K, Rachiotis G, Diamantis A et al (2017) Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection Comparison with the current TNM staging system. Eur J Surg Oncol 43:1350–1356CrossRef Bouliaris K, Rachiotis G, Diamantis A et al (2017) Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection Comparison with the current TNM staging system. Eur J Surg Oncol 43:1350–1356CrossRef
26.
Zurück zum Zitat Hung YS, Chang SC, Liu KH et al (2019) A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification. Asian J Surg 42:85–92CrossRef Hung YS, Chang SC, Liu KH et al (2019) A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification. Asian J Surg 42:85–92CrossRef
27.
Zurück zum Zitat Sun F, Feng M, Guan W (2017) Mechanisms of peritoneal dissemination in gastric cancer. Oncol Lett 14:6991–6998 Sun F, Feng M, Guan W (2017) Mechanisms of peritoneal dissemination in gastric cancer. Oncol Lett 14:6991–6998
28.
Zurück zum Zitat Kanda M, Kodera Y (2016) Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol 22:6829–6840CrossRef Kanda M, Kodera Y (2016) Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol 22:6829–6840CrossRef
29.
Zurück zum Zitat Shimada H, Okazumi S, Koyama M et al (2011) Japanese gastric cancer association task force for research promotion: clinical utility of (1)(8)F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer a systematic review of the literature. Gastric Cancer 14:13–21CrossRef Shimada H, Okazumi S, Koyama M et al (2011) Japanese gastric cancer association task force for research promotion: clinical utility of (1)(8)F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer a systematic review of the literature. Gastric Cancer 14:13–21CrossRef
30.
Zurück zum Zitat Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393CrossRef Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393CrossRef
Metadaten
Titel
Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio
verfasst von
Shunsuke Nakamura
Mitsuro Kanda
Seiji Ito
Yoshinari Mochizuki
Hitoshi Teramoto
Kiyoshi Ishigure
Toshifumi Murai
Takahiro Asada
Akiharu Ishiyama
Hidenobu Matsushita
Chie Tanaka
Daisuke Kobayashi
Michitaka Fujiwara
Kenta Murotani
Yasuhiro Kodera
Publikationsdatum
05.09.2020
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 12/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05739-0

Weitere Artikel der Ausgabe 12/2020

World Journal of Surgery 12/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.